Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CERT is expected to report earnings to fall 27.87% to 10 cents per share on May 01
Q1'25
Est.
$0.11
Q4'24
Beat
by $0.03
Q3'24
Beat
by $0.02
Q2'24
Missed
by $0.03
Q1'24
Est.
$0.10
The last earnings report on February 26 showed earnings per share of 15 cents, beating the estimate of 11 cents. With 3.40M shares outstanding, the current market capitalization sits at 2.86B.